Application of Nanoliposome Alprostadil in the Perioperative Period of Percutaneous Coronary Intervention to Reduce In-Stent Restenosis: A Systematic Review and Meta-Analysis

<div>Funnel plots of occurrence of in-stent restenosis from the included studies (figure created by Review Manager Software version 5.3, The Nordic Cochrane Centre, and The Cochrane Collaboration, 2014).</div>

Journal of Interventional Cardiology

fig4

Figure 4

Figure 4: Application of Nanoliposome Alprostadil in the Perioperative Period of Percutaneous Coronary Intervention to Reduce In-Stent Restenosis: A Systematic Review and Meta-Analysis 

Figure 4 | Application of Nanoliposome Alprostadil in the Perioperative Period of Percutaneous Coronary Intervention to Reduce In-Stent Restenosis: A Systematic Review and Meta-Analysis 